CFTR and cystic fibrosis: Indeed, SLC26A9 has been demonstrated to be a genetic modifier in CF (Sun et al., 2012; Miller et al., 2015), and the CFTR corrector VX-809 partially rescued SLC26A9, probably by facilitating trafficking of F508del-CFTR to the plasma membrane (Strug et al., 2016).